Mark E. Strome, 10% Owner at Zivo Bioscience, Inc. (ZIVO), bought 30,000 shares at $0.08 ($3K) on 2024-08-27, disclosed to the SEC on 2025-01-23.
Open-market purchase of $3k ZIVO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| BEAT | SELL | 2025-12-22 | $895K | — | Filing → |
| AREN | SELL | 2025-01-23 | $372K | — | Filing → |
| ZIVO | BUY | 2024-12-31 | $15K | — | Filing → |